Related Experiment Video
Updated: Jun 18, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Genomic and Phenotypic Characterization of Mupirocin Resistant Staphylococcus aureus Clinical Isolates
Background:
Colonization with Staphylococcus aureus is a risk factor for subsequent infection. Decolonization with the topical antibiotic mupirocin is effective and reduces the risk of subsequent S. aureus infection for both methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) strains but may select for mupirocin-resistant isolates.
Methods:
We characterized oxacillin and mupirocin susceptibility amongst 384 S. aureus strains isolated from clinical samples isolated 2017-2023 in Tampa, Florida, spanning strains collected before and after the onset of the COVID-19 pandemic. Whole genome sequencing of bacterial isolates was conducted in parallel and correlated with drug susceptibility profiles.
Results:
Mupirocin resistance (MupR) was nearly exclusively present in MRSA strains (103/106 97.1% of MupR; 103/299 34.4% of MRSA). Although our hospital protocol for decolonization shifted to povidone iodine in the Post-COVID period, the overall prevalence of MupR did not change in Pre-COVID and Post-COVID samples (28.9% vs 26%). Genotype correlated with antibiotic susceptibility with low level MupR (MupLR), linked to mutations in ileS and high level MupR (MupHR), linked to the presence of mupA . Genome analysis revealed that most MupR strains fell into three sequence types (ST) falling into two major clonal complexes (CC): CC8 ST8 (including Community-Associated MRSA strains USA300 and USA500), CC5 ST5 (associated with Healthcare-Associated MRSA such as USA100), and CC5 ST3390. ST3390 isolates had the highest prevalence of MupR (30/36 83%; MupHR 20/36 55.6%; MupLR 10/36 27.8%).
Conclusions:
Mupirocin resistance was prevalent in our hospital MRSA strains. We also found evidence for emergence and persistence of ST3390 MRSA-MupR strains in Florida.
Key Points:
In a survey of clinical isolates in Florida, 34.4% of MRSA strains were mupirocin resistant. Mupirocin resistance correlated with mutations in ileS or carriage of mupA . We found evidence for emergence of MRSA mupirocin-resistant strains that were sequence type ST3390.
Insights
Mupirocin resistance is common in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates in Florida. This resistance is linked to specific genetic mutations and the emergence of ST3390 MRSA strains.
Area of Science:
- Microbiology
- Infectious Diseases
- Genomics
Background:
- Staphylococcus aureus colonization increases infection risk.
- Mupirocin topical antibiotic decolonization is effective but can select for resistance.
- Understanding mupirocin resistance is crucial for infection control.
Purpose of the Study:
- To characterize oxacillin and mupirocin susceptibility in S. aureus clinical isolates.
- To correlate genotypic profiles with antibiotic resistance patterns.
- To investigate trends in mupirocin resistance before and after the COVID-19 pandemic.
Main Methods:
- Analyzed 384 S. aureus strains from clinical samples (2017-2023, Tampa, Florida).
- Performed whole genome sequencing to correlate with drug susceptibility.
- Assessed susceptibility to oxacillin and mupirocin.
Main Results:
- Mupirocin resistance (MupR) was prevalent, primarily in MRSA strains (34.4%).
- MupR prevalence remained stable pre- and post-COVID-19 pandemic.
- Low-level MupR linked to ileS mutations; high-level MupR linked to mupA carriage.
- ST3390 MRSA strains showed the highest MupR prevalence (83%).
Conclusions:
- Mupirocin resistance is a significant issue in hospital MRSA isolates.
- Evidence suggests the emergence and persistence of ST3390 MRSA strains with mupirocin resistance in Florida.
- Genomic analysis identified key genetic determinants of mupirocin resistance.
Related Concept Videos
Development of Antibiotic Resistance
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

